H. Renz (Marburg, Germany), I. M. Adcock (London, United Kingdom)
CAT-354, an IL-13-neutralising human monoclonal antibody, inhibits airways hyperresponsiveness and eosinophilia in a cynomolgus monkey model of allergen challenge
R. D. May, E. C. Martin, P. D. Monk, N. Brennan, J. Powell, R. J. Wilson, I. K. Anderson (Cambridge, Marlborough, United Kingdom; Worcester, United States Of America)
|  |
IL-15 transpresentation in circulating progenitors of NK cells controls their differentiation potential, STAT6 activation and IL-13 production
B. Azzarone, M. Giuliani, D. Durali, W. Canonica (Villejuif, France; Genoa, Italy)
|  |
The expression of interleukin-13 gene is regulated by nfat1 in human T cells
X. Yao, X. Yao, K. Y. Lee, E. Jazrawi, I. Adcock, P. Barnes (London, United Kingdom; Nanjing, China)
| |
Up regulation of CD23 (FceRII) expression in human airway smooth muscle cells after exposure to IL-13
N. Morelli, F. Blasi, L. Allegra, S. A. Marsico (Naples, Milan, Italy)
| |
Impaired MAP kinase-dependent modulation of transcription factor T-bet in T-lymphocytes from asthmatics - role of dexamethasone
M. Raidl, M. Lux, K. Mueller, F. Montalbano, A. Koch (Cologne, Germany)
| |
Selective decoy-mediated inhibition of activator protein-1 activity in the airways prevents experimental asthmatic inflammation
C. Desmet, P. Gosset, B. Pajak, V. Garzé, P. Lekeux, F. Bureau (Liège, Brussels, Belgium; Lille, France)
| |
Bystander tolerance in experimental asthma: a mouse model
C. L. Van Hove, K. G. Tournoy, R. A. Pauwels, G. F. Joos (Ghent, Belgium)
| |
Modulation of inflammatory cells apoptosis induced by oral tolerance in a model of chronic allergic airway inflammation in guinea pigs
A. S. Nakashima, V. C. Ruiz, F. M. Tayar, C. M. Prado, E. A. Leick-Maldonado, V. L. Capellozi, M. A. Martins, I. F. L. C. Tibério (Sao Paulo, Brazil)
| |